PAPER Perri ER, Parakh S, Vidal M, Mehta P, Ma Y, Walker AK, Atkin JD
SEARCH RESULTS
4111 RESULTS
PAPER Nyuzuki H, Ito S, Nagasaki K, Nitta Y, Matsui N, Saitoh A, Matsui H
Degeneration of dopaminergic neurons and impaired intracellular trafficking in Atp13a2 deficient zebrafish.
IBRO Rep. 2020 Dec;9:1-8. Epub 2020 Jun 1 PubMed: 32529115PAPER Hopfner F, Mueller SH, Szymczak S, Junge O, Tittmann L, May S, Lohmann K, Grallert H, Lieb W, Strauch K, Müller-Nurasyid M, Berger K, Schormair B, Winkelmann J, Mollenhauer B, Trenkwalder C, Maetzler W, Berg D, Kasten M, Klein C, Höglinger GU, Gasser T, Deuschl G, Franke A, Krawczak M, Dempfle A, Kuhlenbäumer G
Private variants in PRKN are associated with late-onset Parkinson's disease.
Parkinsonism Relat Disord. 2020 Jun;75:24-26. Epub 2020 May 11 PubMed: 32442813PAPER Tundo GR, Sbardella D, Santoro AM, Coletta A, Oddone F, Grasso G, Milardi D, Lacal PM, Marini S, Purrello R, Graziani G, Coletta M
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
Pharmacol Ther. 2020 Sep;213:107579. Epub 2020 May 19 PubMed: 32442437PAPER Labanca F, Ullah H, Khan H, Milella L, Xiao J, Dajic-Stevanovic Z, Jeandet P
Therapeutic and Mechanistic effects of Curcumin in Huntington's disease.
Curr Neuropharmacol. 2020 May 22; PubMed: 32442088PAPER Belousov DM, Mikhaylenko EV, Somasundaram SG, Kirkland CE, Aliev G
The Dawn of Mitophagy: What Do We Know by Now?
Curr Neuropharmacol. 2020 May 22; PubMed: 32442087PAPER Heinzel S, Aho VT, Suenkel U, von Thaler AK, Schulte C, Deuschle C, Paulin L, Hantunen S, Brockmann K, Eschweiler GW, Maetzler W, Berg D, Auvinen P, Scheperjans F
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
Ann Neurol. 2020 Aug;88(2):320-331. Epub 2020 Jun 15 PubMed: 32441370PAPER Vuotto C, Battistini L, Caltagirone C, Borsellino G
Gut Microbiota and Disorders of the Central Nervous System.
Neuroscientist. 2020 Oct-Dec;26(5-6):487-502. Epub 2020 May 22 PubMed: 32441219PAPER Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sánchez-Tejerina D, Santos-Fernández T, Folgueira-López MD, Gutiérrez-Gutiérrez J, Ayuso-García B, González de la Aleja J, Benito-León J
Generalized myoclonus in COVID-19.
Neurology. 2020 Aug 11;95(6):e767-e772. Epub 2020 May 21 PubMed: 32439821PAPER Maxan A, Sciacca G, Alpaugh M, Tao Z, Breger L, Dehay B, Ling Z, Chuan Q, Cisbani G, Masnata M, Salem S, Lacroix S, Oueslati A, Bezard E, Cicchetti F
Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates.
Neurobiol Dis. 2020 Jul;141:104951. Epub 2020 May 18 PubMed: 32439599PAPER Sapp E, Seeley C, Iuliano M, Weisman E, Vodicka P, DiFiglia M, Kegel-Gleason KB
Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region.
Neurobiol Dis. 2020 Jul;141:104950. Epub 2020 May 19 PubMed: 32439598PAPER Krach F, Bogiongko ME, Winner B
Decoding Parkinson's disease- iPSC-derived models in the OMICs era.
Mol Cell Neurosci. 2020 Jul;106:103501. Epub 2020 May 18 PubMed: 32439399PAPER Younes K, Miller BL
Neuropsychiatric Aspects of Frontotemporal Dementia.
Psychiatr Clin North Am. 2020 Jun;43(2):345-360. Epub 2020 Apr 8 PubMed: 32439026PAPER Younes K, Miller BL
Frontotemporal Dementia: Neuropathology, Genetics, Neuroimaging, and Treatments.
Psychiatr Clin North Am. 2020 Jun;43(2):331-344. Epub 2020 Apr 8 PubMed: 32439025PAPER Váradi C
Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms.
Biology (Basel). 2020 May 19;9(5) PubMed: 32438686Current Filters
- Date Range : Apr 2020 to Jul 2020 x